Los puntos clave no están disponibles para este artículo en este momento.
Recent treatments for pediatric acute lymphoblastic leukemia (ALL) are founded on risk stratification. We examined the survival rates and prognostic factors of patients over a 20-year period at a single institution.
Lee et al. (Fri,) studied this question.